Informatie:
Fout:
ID
44054
Beschrijving
Study part: Status of treatment blind. A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Trefwoorden
Versies (2)
- 19-06-18 19-06-18 -
- 20-09-21 20-09-21 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
20 september 2021
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Status of treatment blind Pazopanib Macular Degeneration MD1103367
Status of treatment blind
- StudyEvent: ODM
Similar models
Status of treatment blind
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
STATUS OF TREATMENT BLIND (Blind)
C0749659 (UMLS CUI-1)
C2347038 (UMLS CUI-2)
C2347038 (UMLS CUI-2)
Item
Was the treatment blind broken during the study?
text
C0749659 (UMLS CUI [1])
C2347038 (UMLS CUI [2])
C2347038 (UMLS CUI [2])
CL Item
No (N)
CL Item
Yes (Y)
Date and time Blinded Clinical Study study end
Item
Date/time blind broken
datetime
C1264639 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
C2983670 (UMLS CUI [1,3])
C2347038 (UMLS CUI [1,2])
C2983670 (UMLS CUI [1,3])
CL Item
Medical emergency requiring identification of investigational product for further treatment (Medical emergency requiring identification of investigational product for further treatment)
CL Item
Other (Other)
Other
Item
Other, specify
text
C0205394 (UMLS CUI [1])